Agios Pharmaceuticals
AGIO
31.79
+0.07
+0.22%
Agios Pharmaceuticals
US · AGIO
#2841 by market cap
Listed 1970
31.79
+0.07
+0.22%
Live - 5344 symbols - heartbeat 434s ago
· 2026-10-07 19:54
After-hours
31.79
0.00%
- Market cap
- 1.90B
- P/E (TTM)i
- -4.53
- P/Bi
- 1.85
- EPSi
- -7.12
- Div yieldi
- 0.00%
- 52W posi
- 40%
Reader sentiment
Are you bullish or bearish on AGIO?
Anonymous reader poll. Unscientific, not investment advice.
About Agios Pharmaceuticals
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
- Founded
- 2007
- CEO
- Mr. Brian Goff
- Employees
- 540
- Headquarters
- Cambridge, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- agios.com
Company profile
- Exchange
- US
- Symbol
- AGIO
- Market-cap rank
- #2841
- Listing date
- 1970-01-01
- Market cap
- 1.90B
- Float cap
- 1.59B
- Shares out
- 59.70M
- Float shares
- 50.02M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.